Tocilizumabe para tratamento de pacientes com COVID-19 | s.l; s.n; abr. 2021. | LILACS

Main content 1 Search 2 Footer 3

+A A -A High contrast

Tocilizumabe para tratamento de pacientes com COVID-19 / Tocilizumab for the treatment of patients with COVID-19

Brasil. Ministério da Saúde. Coordenação de Monitoramento e Avaliação de Tecnologias em Saúde.

s.l; s.n; abr. 2021.

Non-conventional in Pt | LILACS | ID: biblio-1247374

Responsible library: BR1.1

Subject(s)

Humans; Pneumonia, Viral/drug therapy; Interleukin-6/pharmacology; Coronavirus Infections/drug therapy; Betacoronavirus/drug effects; Antibodies, Monoclonal/therapeutic use; Technology Assessment, Biomedical; Cost-Benefit Analysis

Search on Google

Full text: 1 Index: LILACS Main subject: Pneumonia, Viral / Interleukin-6 / Coronavirus Infections / Betacoronavirus / Antibodies, Monoclonal Type of study: Evaluation_studies / Health_technology_assessment Limits: Humans Language: Pt Year: 2021 Type: Non-conventional

Search on Google

Full text: 1 Index: LILACS Main subject: Pneumonia, Viral / Interleukin-6 / Coronavirus Infections / Betacoronavirus / Antibodies, Monoclonal Type of study: Evaluation_studies / Health_technology_assessment Limits: Humans Language: Pt Year: 2021 Type: Non-conventional